Radio-pathomic maps of glioblastoma identify phenotypes of non-enhancing tumor infiltration associated with bevacizumab treatment response Samuel A. BobholzAlisha HoefsPeter S. LaViolette Research Open access 19 February 2024 Pages: 233 - 241
Correction to: Radio-pathomic maps of glioblastoma identify phenotypes of non-enhancing tumor infiltration associated with bevacizumab treatment response Samuel A. BobholzAlisha HoefsPeter S. LaViolette Correction Open access 18 March 2024 Pages: 243 - 243
Repeat surgery of recurrent glioma for molecularly informed treatment in the age of precision oncology: A risk–benefit analysis Obada T. AlhalabiPhilip Dao TrongChristine Jungk Research Open access 09 February 2024 Pages: 245 - 255
The role of spine stereotactic radiosurgery for patients with breast cancer metastases Suchet TaoriSamuel AdidaPeter C. Gerszten Research 14 February 2024 Pages: 257 - 266
Repeated surgical resections for management of high-grade glioma and its impact on quality of life Jun Min KoayLoizos MichaelidesDavid S. Sabsevitz Research 13 February 2024 Pages: 267 - 273
Utility of molecular markers in predicting local control specific to lung cancer spine metastases treated with stereotactic body radiotherapy Dana ShorAlexander V. LouieHanbo Chen Research 25 March 2024 Pages: 275 - 283
Prognostic factors analysis of diffuse midline glioma Jing JiangWen-bin LiShao-wen Xiao Research Open access 21 February 2024 Pages: 285 - 292
Correction to: Prognostic factors analysis of diffuse midline glioma Jing JiangWen-bin LiShao-wen Xiao Correction Open access 15 March 2024 Pages: 293 - 293
Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years’ experience of a single center Melek Tugce YilmazAlper KahveciogluFaruk Zorlu Research Open access 22 February 2024 Pages: 295 - 303
The diagnostic efficiency of integration of 2HG MRS and IVIM versus individual parameters for predicting IDH mutation status in gliomas in clinical scenarios: A retrospective study Meimei YuYing GeHuicong Shen Research 29 February 2024 Pages: 305 - 313
Diverse learners: learning disabilities and quality of life following mind–body and health education interventions for adults with neurofibromatosis Millan R. KanayaJonathan GreenbergAna-Maria Vranceanu Research 27 February 2024 Pages: 315 - 322
Palliative care for in-patient malignant glioma patients in Germany Larissa FinkBirgitt van OorschotMarcel A. Kamp Research Open access 20 March 2024 Pages: 323 - 338
Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma Phioanh Leia NghiemphuJeremie VitteMarco Giovannini Case Study Open access 19 February 2024 Pages: 339 - 348
Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors James L. RogersThomas WallMarta Penas-Prado Case Study Open access 01 March 2024 Pages: 349 - 359
Comment: Additional factors affecting cognitive function in low grade glioma patients Polina AngelovaMaria Gicheva Correspondence 13 February 2024 Pages: 361 - 362
Letter to the editor: Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: a meta-analysis Peter G. ZakiSanjeev HerrMatthew J. Shepard Correspondence 22 March 2024 Pages: 363 - 364
Harnessing imaging biomarkers for glioblastoma metastasis diagnosis: a correspondence Mohamed JallohSamuel Berchi Kankam Correspondence 23 February 2024 Pages: 365 - 367
Correction to: Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy Carrie E. AndrewsJenny ZilberbergDavid W. Andrews Correction Open access 22 March 2024 Pages: 369 - 369
Correction to: Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study Ko-Ting ChenChiung-Yin HuangKuo-Chen Wei Correction 10 April 2024 Pages: 371 - 371